Shopping Cart
Remove All
Your shopping cart is currently empty
Ersodetug (RZ358) is a fully human monoclonal antibody that targets an allosteric site on the insulin receptor (IR). As a negative modulator of insulin receptor activity, it effectively counteracts refractory hypoglycemia caused by insulin oversecretion, demonstrating significant potential in the study of congenital hyperinsulinism.

| Description | Ersodetug (RZ358) is a fully human monoclonal antibody that targets an allosteric site on the insulin receptor (IR). As a negative modulator of insulin receptor activity, it effectively counteracts refractory hypoglycemia caused by insulin oversecretion, demonstrating significant potential in the study of congenital hyperinsulinism. |
| Synonyms | XOMA 358, RZ-358 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | INSR |
| Cas No. | 2410976-61-1 |
| Isotype | IgG2SA-TM |
| Storage | store at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.